Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Awareness Group's Pablo Diaz Named Visionary Renewable Energy Leader of the Year
-
NeoTerrex Assays 12.87% TREO at Its Revolver Project, Including 2.1% Neodymium Oxide
-
Q Precious & Battery Metals Corp. Announces Closing of First Tranche of Private Placement for $886,000
-
Origin Agritech Obtains New Licenses for Crop Seed Production and GMO Business Operations
-
Xali Gold to Acquire Pico Machay Gold Project in Peru
-
Pasinex Closes Over-Subscribed Non-Brokered Private Placement
-
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases
-
Stellar Bancorp, Inc. Reports Third Quarter 2025 Results
-
Virtus Investment Partners Announces Financial Results for Third Quarter 2025
-
General Dynamics Reports Third-Quarter 2025 Financial Results
-
HCA Healthcare Reports Third Quarter 2025 Results
-
P&G Announces Fiscal Year 2026 First Quarter Results
-
Caliber to Sponsor & Attend Chainlink’s 2025 SmartCon Conference
-
Aldebaran Announces the Formation of Centauri Minerals and Completion of C$5.7 Million Seed Financing
-
Hospital for Special Surgery Study Shows AI Tool Effectively Prepares Patients for Joint Replacement Surgery
-
Jugbow Care Initiative Launches Scholarship at Alula Film Festival, Merging Cinema and Compassionate Action
-
ACCO Brands Corporation Declares Quarterly Dividend
-
Bybit TradFi Launches Referral Program Offering Up to 30% in Rewards
-
Pulse Biosciences Announces First Enrollment in the NANOCLAMP AF Study
-
Schneider Electric Highlights Innovation in 800 VDC Power Systems in Support of NVIDIA’s Next-Generation GPUs
-
Lufax Announces Change in Chief Risk Officer
-
Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025
-
Ryan Named One of the 2025 Best Places to Work in Kansas City
-
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
-
Aeluma Quantum Photonics Paper Accepted to SPIE Photonics West Conference January 17 – 22, 2026 in San Francisco, California
-
Dallas Area Rapid Transit Opens New Regional Rail Line, Connecting Communities
-
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
-
BitMart Launches Halloween “Trick or Trade” Event as BMX Gains Market Momentum and BitMart Card Adoption Accelerates
-
Advantage Solutions Announces Date for its Third Quarter 2025 Financial Results and Conference Call
-
GURU Organic Energy Continues Its Record-Breaking Streak on Amazon Prime Days in October
-
Green Thumb Industries to Report Third Quarter 2025 Financial Results on November 5, 2025
-
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2025 Financial Results
-
Electrovaya ranked 3rd in Canada's Enterprise-Industry Leaders winners in Deloitte's Technology Fast 50TM program
-
ECARX Antora® and Cloupeak® Solutions Expand into UK with Launch of Geely EX5
-
Aclara To Build First Heavy Rare Earths Separation Facility in U.S. With a Secured Sustainable Ionic Clay Feed by Mid-2028
-
T1 Energy Advances G2_Austin Development with Capital Formation Progress
-
Havila Kystruten AS: Notice of extraordinary general meeting November 7th, 2025
-
Scholars from China and abroad gather in Nanping, Fujian for cross-cultural dialogues on Zhu Xi's legacy
-
Scholars from China and abroad gather in Nanping, Fujian for cross-cultural dialogues on Zhu Xi's legacy
-
New Crypto Mutuum Finance (MUTM) Crosses $17.8 Million Raised as Holder Count Nears 17,500
-
Kontoor Brands Declares Quarterly Dividend, a 2 Percent Increase
-
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ET
-
Last Call for TSC Trick & Trade Sale Discounts
-
Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis
-
Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
-
Gorman-Rupp Announces Increase in Quarterly Cash Dividend
-
Booz Allen Hamilton Announces Second Quarter Fiscal Year 2026 Results
-
Avery Dennison Declares Quarterly Dividend
-
Weekly Recap: 11 Finance Press Releases You Need to See
-
Last Chance for SureShotFX Halloween Special Offer!
